Sun, May 19, 2013
A A A
Welcome Guest
Free Trial RSS
New! Family Office and Investor Database with 11,750 contacts
Industry Updates

Sciens launches managed account analysis tool for hedge fund investors

Friday, November 09, 2012
Opalesque Industry Update – Sciens Alternative Investments, part of the Sciens Capital Management Group and provider of single- and multi-strategy funds of hedge funds and managed account services, today announces the launch of the Sciens Managed Account Risk Technologies (S.M.A.R.T.), an interactive risk analytics and portfolio construction engine that enables investors to evaluate their Hedge Fund portfolios and aggregated fund exposures on Sciens Managed Account Platform (MAP).

Mr John Godden, Head of Managed Account Platform, Sciens said, “The main challenge for Hedge Fund investors is insufficient and / or out-of-date information on which to base investment decisions. We created SMART in response to a growing desire among institutional investors to manage Hedge Fund investments in the same way as their traditional Equity / Bond portfolios. SMART is unique because it draws upon up-to-date (T+2) information from our managed account platform and provides the tools for highly accurate analysis and modelling to a much deeper level than previously possible.

“Initial investor feedback indicates there is a keen appetite for this cutting-edge risk analysis tool. It allows them to obtain greater information and exercise more control over their Hedge Fund investments, which is highly important in light of the increasing focus on governance,” continued Mr Godden.

(press release)

Sciens Capital Management Group is an independent alternative asset manager with approximately US$4.8 billion in assets under management in funds of hedge funds, advisory, private equity and real assets. The Group employs over 100 people globally with its principal offices in New York, London, Guernsey and Athens. Sciens Managed Account Platform is an investment vehicle that can be used to replicate alternative investment strategies, e.g., hedge fund investments.

www.sciensam.com

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Banner
Today's Exclusives Today's Other Voices Banner More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing
  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Goldman offers hedge funds to the 99%[more]

    From TheStreet.com: Goldman Sachs said Thursday it is bringing the sophisticated trading strategies of Wall Street hedge funds to individual investors with investment portfolio's and retirement accounts as small as $1000. The bank's investment management unit, Goldman Sachs Asset Management, i

  2. Opalesque Exclusive: New research examines quantitative trend following as an equity risk hedge[more]

    Bailey McCann, Opalesque New York: New research from Nigol Koulajian founder and CIO, and Paul Czkwianianc, Head of Research at Quest Partners, a New York-based systematic fund, looks at how quantitative trend following could be used

  3. People – Jupiter switches lead manager on alternative UCITS fund, Dr. Dermot F Smurfit appointed as Chairman of the ML Capital Group[more]

    Jupiter switches lead manager on alternative UCITS fund From Citywire.co.uk: Jupiter has named Mike Buhl-Nielsen as lead manager on its Europe-focused long/short equity fund, the asset management company has announced… Full article:

  4. Launches – Blackstone preparing launch of ‘super’ hedge fund, Paulson said to team with insurer for new low-tax merger fund[more]

    Blackstone preparing launch of ‘super’ hedge fund From FT.com: Blackstone is preparing to launch a “super” hedge fund to cherry-pick the best trades from the hundreds of third-party hedge funds it invests with, in an effort to try to recapture the outsize returns the $2tn industry was on

  5. Due diligence - an in-depth medical analysis: Thus far, it has been actuarial analysis that has largely been relied upon to steer the decision making process. However, the medical data utilised in such analysis may be incomplete, rendering the conclusions drawn probably worthless.